Efficacy and safety of Shenmayizhi decoction as an adjuvant treatment for vascular dementia: Study protocol for a randomized controlled trial
This study will provide evidences to evaluate the efficacy and safety of SMYZD in combination with GBEs in treatment of VaD, as well as the adjuvant role of SMYZD in combination.
Trial is registered at Chinese Clinical Trial Registry:
ChiCTR1800017359.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Clinical Trial Source Type: research
More News: Alzheimer's | Brain | China Health | Clinical Trials | Complementary Medicine | Dementia | Eyes | Ginkgo | Herbs | Internal Medicine | Men | National Institutes of Health (NIH) | Neurology | Stroke | Study